MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    High cost of medications for Parkinson’s Disease patients in a rural population of Gujarat, India

    A. Pandya, E. Albert-Stone, A. Deb, S. Desai (Worcester, MA, USA)

    Objective: To understand the economic burden of the cost of Parkinson’s Disease (PD) medications for outpatients receiving care at Shree Krishna Hospital (SKH)  in Karamsad,…
  • 2019 International Congress

    Cognitive impairment in patients with Parkinson’s syndrome

    SH. Rakhimova, I. Usmonaliev, Y. Musaeva (Tashkent, Uzbekistan)

    Objective: Study the principle of cognitive impairment in Parkinson's syndrome (brain cerebral circulation disorder, backdrop of atherosclerosis). Background: Parkinsonism-neurologic syndrome is a disorderly degenerative disease…
  • 2019 International Congress

    Prevalence of Parkinson’s disease and parkinsonism in Kyrgyzstan

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: Aim of the study is to determine frequency and overall picture of disease characteristics, evaluation and treatment of patients with Parkinson’s disease (PD) and…
  • 2019 International Congress

    Prevalence of advanced Parkinson’s disease in Thai patients with Parkinson’s disease using the Consensus on the Definition of Advance Parkinson’s disease (CEPA Study): A single-center study

    J. Srikajon, P. Srivanitchapoom, Y. Pitakpatapee, A. Pisarnpong, T. Sangpeamsook, A. Suengtaworn (Bangkok, Thailand)

    Objective: To identify the prevalence of APD in Thai PD patients who were registered to Movement disorders clinic at Siriraj Hospital, Thailand. The demographic data…
  • 2019 International Congress

    Cough sensitivity and aspiration pneumonia in Parkinson’s disease

    S. Tomita, T. Oeda, S. Takaya, M. Kohsaka, K. Park, A. Umemura, Y. Mori, T. Ishihara, S. Nomoto, M. Tahara, K. Yamamoto, H. Sawada (Kyoto, Japan)

    Objective: We hypothesized that decreased cough sensitivity is crucial to the development of aspiration pneumonia in Parkinson’s disease (PD). We examined the relationship between cough…
  • 2019 International Congress

    Rare manifestation of CNS Lupus: Parkinsonism

    C. Wantaneeyawong, K. Kumchana (Chiang Mai, Thailand)

    Objective: To describe clinical and imaging features of a SLE patient who presented with parkinsonism which is a rare manifestation of NPSLE and the result…
  • 2019 International Congress

    Effectiveness of exome sequencing in Parkinson’s disease of Chinese population

    YW. Zhao, HX. Pan, L. Jiang, Y. He, Q. Zeng, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: The aim of this study was to evaluate rare damaging variants in disease-causing gene of Parkinson’s disease (PD) and other movement disorders, and to…
  • 2019 International Congress

    Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia

    X. Ren, J. Lin, S. Luo, C. Goetz, G. Stebbins, E. Cubo (Burgos, Spain)

    Objective: To assess differential item functioning (DIF) in the Unified Dyskinesia Rating Scale (UDysRS) to determine if the duration of Parkinson’s Disease (PD) and/or duration…
  • 2019 International Congress

    Examining supplementary motor area-primary motor cortex connectivity in tremor-dominant Parkinson’s disease using a novel transcranial magnetic stimulation protocol to inform clinical practice

    BK. Rurak, J. Rodrigues, B. Power, P. Drummond, AM. Vallence (Murdoch, Australia)

    Objective: Objectives: (1) Measure test re-test reliability of dual-coil transcranial magnetic stimulation (TMS) measures of supplementary motor area-primary motor cortex connectivity (SMA-M1 connectivity). (2) Investigate…
  • 2019 International Congress

    A Case of Pregabalin induced Parkinsonism

    BC. Ari, F. Mayda Domac, G. Ozgen Kenangil (Istanbul, Turkey)

    Objective: Present a case of parkinsonism after administration of pregabalin, a rare case Background: Drug induced parkinsonism is the second common movement disorders after Parkinson’s…
  • « Previous Page
  • 1
  • …
  • 194
  • 195
  • 196
  • 197
  • 198
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley